Skip to contentS
Selectis Health, Inc.
S
GBCSSelectis Health, Inc. Q2 2021 · 10-Q
Revenue$6.01M$6.01M+17.2% vs Q2 2020 Net Income-$678.78K-$678.78KN/M vs Q2 2020 EPS Diluted-$0.26-$0.26N/M vs Q2 2020 Operating Income$2,063−99.9% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Selectis Health, Inc. · CIK 727346 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$195,241N/M Margins · derivedOperating margin0.0%−32.2 pt vs Q2 2020
Net margin-11.3%−33.2 pt vs Q2 2020
ended Jun 30, 2021 · filed Aug 16, 2021 · 47 d after period end